Forgot your password?
New user?
Document Actions
Origin BioMed
"I was most impressed with the level of due diligence conducted by all IC participants and feel very fortunate to have them on board! With some 80 angels now invested in Origin, I can say that IC is the best angel organization that I have worked with."
-- Bob Cervelli, CEO
Origin BioMed Inc., Halifax,
Canada, is an innovative OTC drug company currently expanding North
American markets for its exclusive family of over-the-counter drugs for
neuropathic pain management. The company's patented product brand,
Neuragen®, targets the neuropathic pain market listed primarily in the
diabetic sections of drug stores. Neuragen is the most effective Rx or
OTC offering on the market today.